Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China issued its long-awaited three-year plan for its healthcare reform, and unveiled how the country will allocate RMB 850 billion ($124 billion) in the next three years

Related Content

Government Funding Accelerates Venture Interest In China
Philips Acquires Shanghai Apex, Targets Low-End Ultrasound Market In Wake Of China Healthcare Reform
China's Government Investment, Policies Sustain IVD Market With High Double-digit Growth
China Healthcare Industry Will See A Strong 2010: Morgan Stanley
China Earnings Roundup: China Medicine, China Biologic, 3SBio Post Strong Growth
Universal Healthcare Models In Asia Offer Dose Of Reality
China’s Central Government To Invest $17 Billion In Healthcare Reform In 2009
Sanofi-Aventis Sees Diversifying In China As Key To Success; Expands Capacity For Diabetes Treatment Lantus
Healthcare Reform Brings Little Short-term Benefit For China’s Pharmaceutical Companies
China’s Healthcare Reform To Spur Vaccine Market Expansion



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts